75 related articles for article (PubMed ID: 24942130)
1. PDE4D inhibitors: a potential strategy for the treatment of memory impairment?
Bruno O; Ricciarelli R; Prickaerts J; Parker L; Fedele E
Neuropharmacology; 2014 Oct; 85():290-2. PubMed ID: 24942130
[No Abstract] [Full Text] [Related]
2. New insights into selective PDE4D inhibitors: 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) structural development and promising activities to restore memory impairment.
Brullo C; Ricciarelli R; Prickaerts J; Arancio O; Massa M; Rotolo C; Romussi A; Rebosio C; Marengo B; Pronzato MA; van Hagen BTJ; van Goethem NP; D'Ursi P; Orro A; Milanesi L; Guariento S; Cichero E; Fossa P; Fedele E; Bruno O
Eur J Med Chem; 2016 Nov; 124():82-102. PubMed ID: 27560284
[TBL] [Abstract][Full Text] [Related]
3. Effects of rolipram and roflumilast, phosphodiesterase-4 inhibitors, on hypertension-induced defects in memory function in rats.
Jabaris SG; Sumathy H; Kumar RS; Narayanan S; Thanikachalam S; Babu CS
Eur J Pharmacol; 2015 Jan; 746():138-47. PubMed ID: 25446433
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase-4 inhibitors ameliorates cognitive deficits in deoxycorticosterone acetate induced hypertensive rats via cAMP/CREB signaling system.
Jabaris SS; Sumathy H; Girish R; Narayanan S; Sugumar M; Saravana Babu C; Thanikachalam S; Thanikachalam M
Brain Res; 2015 Oct; 1622():279-91. PubMed ID: 26168894
[TBL] [Abstract][Full Text] [Related]
5. GSK356278, a potent, selective, brain-penetrant phosphodiesterase 4 inhibitor that demonstrates anxiolytic and cognition-enhancing effects without inducing side effects in preclinical species.
Rutter AR; Poffe A; Cavallini P; Davis TG; Schneck J; Negri M; Vicentini E; Montanari D; Arban R; Gray FA; Davies CH; Wren PB
J Pharmacol Exp Ther; 2014 Jul; 350(1):153-63. PubMed ID: 24784567
[TBL] [Abstract][Full Text] [Related]
6. GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses.
Bruno O; Fedele E; Prickaerts J; Parker LA; Canepa E; Brullo C; Cavallero A; Gardella E; Balbi A; Domenicotti C; Bollen E; Gijselaers HJ; Vanmierlo T; Erb K; Limebeer CL; Argellati F; Marinari UM; Pronzato MA; Ricciarelli R
Br J Pharmacol; 2011 Dec; 164(8):2054-63. PubMed ID: 21649644
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of PDE IV inhibitors. First asymmetric synthesis of two of GlaxoSmithKline's highly potent Rolipram analogues.
Zhmurov PA; Sukhorukov AY; Chupakhin VI; Khomutova YV; Ioffe SL; Tartakovsky VA
Org Biomol Chem; 2013 Dec; 11(46):8082-91. PubMed ID: 24169629
[TBL] [Abstract][Full Text] [Related]
8. Effects of selective phosphodiesterases-4 inhibitors on learning and memory: a review of recent research.
Peng S; Sun H; Zhang X; Liu G; Wang G
Cell Biochem Biophys; 2014 Sep; 70(1):83-5. PubMed ID: 24699857
[TBL] [Abstract][Full Text] [Related]
9. Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease.
Giralt A; Saavedra A; Carretón O; Xifró X; Alberch J; Pérez-Navarro E
Hum Mol Genet; 2011 Nov; 20(21):4232-47. PubMed ID: 21835884
[TBL] [Abstract][Full Text] [Related]
10. Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice.
Zhang C; Xu Y; Chowdhary A; Fox D; Gurney ME; Zhang HT; Auerbach BD; Salvi RJ; Yang M; Li G; O'Donnell JM
Neuropsychopharmacology; 2018 Oct; 43(11):2299-2309. PubMed ID: 30131563
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme.
Zhang HT; Huang Y; Jin SL; Frith SA; Suvarna N; Conti M; O'Donnell JM
Neuropsychopharmacology; 2002 Oct; 27(4):587-95. PubMed ID: 12377395
[TBL] [Abstract][Full Text] [Related]
12. The induction of cyclic nucleotide phosphodiesterase 4 gene (PDE4D) impairs memory in a water maze task.
Giorgi M; Modica A; Pompili A; Pacitti C; Gasbarri A
Behav Brain Res; 2004 Sep; 154(1):99-106. PubMed ID: 15302115
[TBL] [Abstract][Full Text] [Related]
13. Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats.
Nagakura A; Niimura M; Takeo S
Br J Pharmacol; 2002 Apr; 135(7):1783-93. PubMed ID: 11934820
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase inhibitors enhance object memory independent of cerebral blood flow and glucose utilization in rats.
Rutten K; Van Donkelaar EL; Ferrington L; Blokland A; Bollen E; Steinbusch HW; Kelly PA; Prickaerts JH
Neuropsychopharmacology; 2009 Jul; 34(8):1914-25. PubMed ID: 19262466
[TBL] [Abstract][Full Text] [Related]
15. The selective inhibition of type IV phosphodiesterase attenuates the severity of the acute pancreatitis in rats.
Mersin H; İrkin F; Berberoglu U; Gülben K; Özdemir H; Öngürü Ö
Dig Dis Sci; 2009 Dec; 54(12):2577-82. PubMed ID: 19117125
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of new 3,6-diaryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine analogs as potential phosphodiesterase-4 inhibitors in NIH-3T3 mouse fibroblastic cells.
Baeeri M; Foroumadi A; Motamedi M; Yahya-Meymandi A; Firoozpour L; Ostad SN; Shafiee A; Souzangarzadeh S; Abdollahi M
Chem Biol Drug Des; 2011 Sep; 78(3):438-44. PubMed ID: 21722319
[TBL] [Abstract][Full Text] [Related]
17. Effects of protein kinase A and G inhibitors on hippocampal cholinergic markers expressions in rolipram- and sildenafil-induced spatial memory improvement.
Hosseini-Sharifabad A; Ghahremani MH; Sabzevari O; Naghdi N; Abdollahi M; Beyer C; Bollen E; Prickaerts J; Roghani A; Sharifzadeh M
Pharmacol Biochem Behav; 2012 May; 101(3):311-9. PubMed ID: 22306745
[TBL] [Abstract][Full Text] [Related]
18. Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer's disease.
Ricciarelli R; Brullo C; Prickaerts J; Arancio O; Villa C; Rebosio C; Calcagno E; Balbi M; van Hagen BT; Argyrousi EK; Zhang H; Pronzato MA; Bruno O; Fedele E
Sci Rep; 2017 Apr; 7():46320. PubMed ID: 28402318
[TBL] [Abstract][Full Text] [Related]
19. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
Rutten K; Prickaerts J; Hendrix M; van der Staay FJ; Sik A; Blokland A
Eur J Pharmacol; 2007 Mar; 558(1-3):107-12. PubMed ID: 17207788
[TBL] [Abstract][Full Text] [Related]
20. Molecular Bases of PDE4D Inhibition by Memory-Enhancing GEBR Library Compounds.
Prosdocimi T; Mollica L; Donini S; Semrau MS; Lucarelli AP; Aiolfi E; Cavalli A; Storici P; Alfei S; Brullo C; Bruno O; Parisini E
Biochemistry; 2018 May; 57(19):2876-2888. PubMed ID: 29652483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]